{"article_title": "What if detecting Parkinson's and Alzheimer's was just skin deep?", "article_keywords": ["diseases", "proteins", "parkinsons", "alzheimers", "rodriguezleyva", "brain", "patients", "tissue", "deep", "skin", "test", "detecting"], "article_url": "http://medcitynews.com/2015/02/detecting-parkinsons-alzheimers-just-skin-deep/", "article_text": "For diseases like Parkinson\u2019s and Alzheimer\u2019s, it seems like symptoms are a function of what\u2019s going on deep down inside of whoever is afflicted \u2013 a reflection of something happening at the core. But what if detection could be right in front of our faces, just on the surface of a patient\u2019s skin?\n\nDr. Ildefonso Rodriguez-Leyva and colleagues from the University of San Luis Potosi, Mexico, believe examining skin tissue could be uncover hidden brain disorders.\n\nThis early-stage work has indicated that abnormal proteins that accumulate in the brain with these disorders are also found on the skin, which with advanced tests could contribute to early diagnosis to prevent loss of brain tissue before irreversible damage has taken place.\n\nAdvertisement\n\nIn a developing embryo, skin and brain tissue have the same origin, so the researchers believe it could indicate disorders that occur in the mind later in life.\n\nAs BBC reported:\n\nPost-mortem studies of people with Parkinson\u2019s also reveal that the same protein deposits which occur in the brain with this condition also accumulate in the skin. To test if the same was true in life as after death, the researchers recruited 65 volunteers \u2013 12 who were healthy controls and the remaining 53 who had either Parkinson\u2019s disease, Alzheimer\u2019s or another type of dementia. They took a small skin biopsy from behind the ear of each volunteer to test in their laboratory for any telltale signs of disease. Specifically, they looked for the presence of two proteins \u2013 tau and alpha-synuclein. The 20 people with Alzheimer\u2019s and the 16 with Parkinson\u2019s had raised levels of both these proteins in their skin compared to the healthy controls and the patients with other types of dementia. The people with Parkinson\u2019s also had higher levels of alpha-synuclein protein.\n\n\u201cMore research is needed to confirm these results, but the findings are exciting because we could potentially begin to use skin biopsies from living patients to study and learn more about these diseases,\u201d said Dr Rodriguez-Leyva, who will soon present his findings to the annual meeting of the American Academy of Neurology. \u201cThis new test offers a potential biomarker that may allow doctors to identify and diagnose these diseases earlier on.\u201d\n\n[Photo from Flickr user Thami C\u00e9sar]", "article_metadata": {"description": "For diseases like Parkinson\u2019s and Alzheimer\u2019s, it seems like symptoms are a function of what\u2019s going on deep down inside of whoever is afflicted \u2013 a reflection of something happening at the core. But what if detection could be right in front of our faces, just on the surface of a patient\u2019s skin? Dr. Ildefonso Rodriguez-Leyva and colleagues from the University of San Luis Potosi, Mexico, believe examining skin tissue could be uncover hidden brain disorders. This early-stage work has indicated that abnormal proteins that accumulate in the brain with these disorders are also found on the skin, which with advanced tests could contribute to early diagnosis to prevent loss of brain tissue before irreversible damage has taken place. In a developing embryo, skin and brain tissue have the same origin, so the researchers believe it could indicate disorders that occur in the mind later in life. As BBC reported: Post-mortem studies of people with Parkinson\u2019s also reveal that the same protein deposits which occur in the brain with this condition also accumulate in the skin. To test if the same was true in life as after death, the researchers recruited 65 volunteers \u2013 12 who were healthy controls and the remaining 53 who had either Parkinson\u2019s disease, Alzheimer\u2019s or another type of dementia. They took a small skin biopsy from behind the ear of each volunteer to test in their laboratory for any telltale signs of disease. Specifically, they looked for the presence of two proteins \u2013 tau and alpha-synuclein. The 20 people with Alzheimer\u2019s and the 16 with Parkinson\u2019s had raised levels of both these proteins in their skin compared to the healthy controls and the patients with other types of dementia. The people with Parkinson\u2019s also had higher levels of alpha-synuclein protein. \u201cMore research is needed to confirm these results, but the findings are exciting because we could potentially begin to use skin biopsies from living patients to study and learn more about these diseases,\u201d said Dr Rodriguez-Leyva, who will soon present his findings to the annual meeting of the American Academy of Neurology. \u201cThis new test offers a potential biomarker that may allow doctors to identify and diagnose these diseases earlier on.\u201d [Photo from Flickr user Thami C\u00e9sar]", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "For diseases like Parkinson\u2019s and Alzheimer\u2019s, it seems like symptoms are a function of what\u2019s going on deep down inside of whoever is afflicted \u2013 a reflection of something happening at the core. But what if detection could be right in front of our faces, just on the surface of a patient\u2019s skin? Dr. Ildefonso Rodriguez-Leyva and colleagues from the University of San Luis Potosi, Mexico, believe examining skin tissue could be uncover hidden brain disorders. This early-stage work has indicated that abnormal proteins that accumulate in the brain with these disorders are also found on the skin, which with advanced tests could contribute to early diagnosis to prevent loss of brain tissue before irreversible damage has taken place. In a developing embryo, skin and brain tissue have the same origin, so the researchers believe it could indicate disorders that occur in the mind later in life. As BBC reported: Post-mortem studies of people with Parkinson\u2019s also reveal that the same protein deposits which occur in the brain with this condition also accumulate in the skin. To test if the same was true in life as after death, the researchers recruited 65 volunteers \u2013 12 who were healthy controls and the remaining 53 who had either Parkinson\u2019s disease, Alzheimer\u2019s or another type of dementia. They took a small skin biopsy from behind the ear of each volunteer to test in their laboratory for any telltale signs of disease. Specifically, they looked for the presence of two proteins \u2013 tau and alpha-synuclein. The 20 people with Alzheimer\u2019s and the 16 with Parkinson\u2019s had raised levels of both these proteins in their skin compared to the healthy controls and the patients with other types of dementia. The people with Parkinson\u2019s also had higher levels of alpha-synuclein protein. \u201cMore research is needed to confirm these results, but the findings are exciting because we could potentially begin to use skin biopsies from living patients to study and learn more about these diseases,\u201d said Dr Rodriguez-Leyva, who will soon present his findings to the annual meeting of the American Academy of Neurology. \u201cThis new test offers a potential biomarker that may allow doctors to identify and diagnose these diseases earlier on.\u201d [Photo from Flickr user Thami C\u00e9sar]", "title": "What if detecting Parkinson\u2019s and Alzheimer\u2019s was just skin deep?", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/16004072511_e10ca54238_z.jpg", "updated_time": "2015-02-26T15:05:06-04:00", "url": "http://medcitynews.com/2015/02/detecting-parkinsons-alzheimers-just-skin-deep/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/16004072511_e10ca54238_z.jpg", "description": "For diseases like Parkinson\u2019s and Alzheimer\u2019s, it seems like symptoms are a function of what\u2019s going on deep down inside of whoever is afflicted \u2013 a reflection of something happening at the core. But what if detection could be right in front of our faces, just on the surface of a patient\u2019s skin? Dr. Ildefonso Rodriguez-Leyva and colleagues from the University of San Luis Potosi, Mexico, believe examining skin tissue could be uncover hidden brain disorders. This early-stage work has indicated that abnormal proteins that accumulate in the brain with these disorders are also found on the skin, which with advanced tests could contribute to early diagnosis to prevent loss of brain tissue before irreversible damage has taken place. In a developing embryo, skin and brain tissue have the same origin, so the researchers believe it could indicate disorders that occur in the mind later in life. As BBC reported: Post-mortem studies of people with Parkinson\u2019s also reveal that the same protein deposits which occur in the brain with this condition also accumulate in the skin. To test if the same was true in life as after death, the researchers recruited 65 volunteers \u2013 12 who were healthy controls and the remaining 53 who had either Parkinson\u2019s disease, Alzheimer\u2019s or another type of dementia. They took a small skin biopsy from behind the ear of each volunteer to test in their laboratory for any telltale signs of disease. Specifically, they looked for the presence of two proteins \u2013 tau and alpha-synuclein. The 20 people with Alzheimer\u2019s and the 16 with Parkinson\u2019s had raised levels of both these proteins in their skin compared to the healthy controls and the patients with other types of dementia. The people with Parkinson\u2019s also had higher levels of alpha-synuclein protein. \u201cMore research is needed to confirm these results, but the findings are exciting because we could potentially begin to use skin biopsies from living patients to study and learn more about these diseases,\u201d said Dr Rodriguez-Leyva, who will soon present his findings to the annual meeting of the American Academy of Neurology. \u201cThis new test offers a potential biomarker that may allow doctors to identify and diagnose these diseases earlier on.\u201d [Photo from Flickr user Thami C\u00e9sar]", "card": "summary", "title": "What if detecting Parkinson's and Alzheimer's was just skin deep? - MedCity News"}, "fb": {"app_id": 148725768475669}, "article": {"section": "Daily", "tag": "University of San Luis Potosi", "published_time": "2015-02-26T14:37:18-04:00", "modified_time": "2015-02-26T15:05:06-04:00"}, "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,Alzheimers, biomarkers, Ildefonso Rodriguez-Leyva, Parkinson's Disease, University of San Luis Potosi, , MedCity News", "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "article_summary": "But what if detection could be right in front of our faces, just on the surface of a patient\u2019s skin?\nDr. Ildefonso Rodriguez-Leyva and colleagues from the University of San Luis Potosi, Mexico, believe examining skin tissue could be uncover hidden brain disorders.\nFor diseases like Parkinson\u2019s and Alzheimer\u2019s, it seems like symptoms are a function of what\u2019s going on deep down inside of whoever is afflicted \u2013 a reflection of something happening at the core.\nAdvertisementIn a developing embryo, skin and brain tissue have the same origin, so the researchers believe it could indicate disorders that occur in the mind later in life.\nThe 20 people with Alzheimer\u2019s and the 16 with Parkinson\u2019s had raised levels of both these proteins in their skin compared to the healthy controls and the patients with other types of dementia."}